Wells Fargo & Company Rx Sight, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Rx Sight, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,129 shares of RXST stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,129

Previous 48,055 45.63%

Holding current value

$1.2 Million

Previous $2.89 Million 55.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.78 - $57.04 $894,142 - $1.25 Million	-21,926 Reduced 45.63%	26,129 $1.29 Million
Q2 2024 Aug 13, 2024	BUY	$50.42 - $64.29 $611,997 - $780,352	12,138 Added 33.79%	48,055 $2.89 Million
Q1 2024 May 10, 2024	BUY	$35.51 - $57.92 $397,392 - $648,182	11,191 Added 45.26%	35,917 $1.85 Million
Q4 2023 Feb 09, 2024	SELL	$20.91 - $40.9 $34,752 - $67,975	-1,662 Reduced 6.3%	24,726 $996,000
Q3 2023 Nov 13, 2023	SELL	$27.05 - $33.37 $48,365 - $59,665	-1,788 Reduced 6.35%	26,388 $735,000
Q2 2023 Aug 15, 2023	BUY	$16.37 - $28.9 $150,587 - $265,851	9,199 Added 48.47%	28,176 $811,000
Q1 2023 May 12, 2023	BUY	$12.58 - $16.68 $69,403 - $92,023	5,517 Added 40.99%	18,977 $316,000
Q4 2022 Feb 13, 2023	SELL	$9.93 - $14.2 $49,580 - $70,900	-4,993 Reduced 27.06%	13,460 $170,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $15.85 $46,304 - $65,587	-4,138 Reduced 18.32%	18,453 $222,000
Q2 2022 Aug 12, 2022	SELL	$10.61 - $16.66 $136,869 - $214,914	-12,900 Reduced 36.35%	22,591 $318,000
Q1 2022 May 16, 2022	BUY	$8.97 - $14.03 $16,531 - $25,857	1,843 Added 5.48%	35,491 $440,000
Q4 2021 Feb 14, 2022	BUY	$9.52 - $13.81 $69,105 - $100,246	7,259 Added 27.51%	33,648 $379,000
Q3 2021 Nov 15, 2021	BUY	$11.85 - $17.32 $312,709 - $457,057	26,389 New	26,389 $334,000

Others Institutions Holding RXST

# of Institutions

225

Shares Held

32.3M

Call Options Held

394K

Put Options Held

32K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.27B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Rx Sight, Inc. Transaction History